Jump to content
RemedySpot.com

New discussion: PhV in medical research - XXVI

Rate this topic


Guest guest

Recommended Posts

Dear members,Moving to POST-APPROVAL SAFETY DATA MANAGEMENTThe definition and standards for AE/ADR expedited reporting are more or less same as in Pre-Approval safety data management and that what we learnt in older posts.In this regard, lets see the concept of "Class ADR" “Class ADRs†should not automatically be considered to be expected for the subject drug (e.g.Drug X) Should be considered expected only if described as specifically occurring with the product in the

local/regional product labelinge.g. “As with other drugs of this class, the following undesirable effect occurs with Drug X.†OR “Drugs of this class, including Drug X, can cause...†likewise.Regards,Dr. Vijay M. katekhayePostgraduate StudentDept. of Pharmacology,LTMMC & LTMGH, Sion,Mumbai - 400 022 Ph - +919619313060

Link to comment
Share on other sites

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...